Lantheus Holdings' presentations at the 2023 Society for Nuclear Medicine and Molecular Imaging Annual Meeting will showcase its PYLARIFY AI technology. This exposure may increase the company's visibility and credibility in the industry, potentially leading to increased interest from investors and customers, and ultimately having a positive impact on its stock price in the short term.